Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K/A | 10-Q | 10-Q |
| Revenue growth | | | -100.0% | -100.0% | -100.0% | -66.6% | -19.0% | 5.2% |
| Costs and expenses: | | | | | | | | |
| Selling, general and administrative | | | 1.1 | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 |
| Total | | | 1.1 | 1.2 | 1.1 | 1.1 | 1.2 | 1.4 |
| Operating loss | | | -1.1 | -1.2 | -1.1 | -0.1 | 1.0 | 1.5 |
| Operating margin | | | | | | -8.3% | 44.3% | 53.2% |
| |
| Total other expense | | | | | | | | |
| Loss from investments in unconsolidated entities, net | | | -1.4 | -1.3 | -0.5 | -0.5 | -0.9 | -0.8 |
| Total other expense | | | -1.8 | -1.7 | -0.8 | -0.8 | -1.1 | -1.0 |
| (Loss) income before income taxes | | | -2.5 | -2.5 | -1.6 | -0.6 | 0.1 | 0.7 |
| Provision for income taxes | | | -0.2 | -0.2 | -0.5 | -0.7 | -0.7 | -0.7 |
| Net (loss) income | | | -3.1 | -3.1 | -2.4 | -1.7 | -0.7 | -0.3 |
| Net loss attributable to noncontrolling interests | | | 0.4 | 0.4 | 0.2 | 0.1 | | |
| Net (loss) income attributable to U.S. Neurosurgical Holdings, Inc. | | | -2.3 | -2.4 | -1.9 | -1.2 | -0.5 | 0.0 |
| |
| Basic net | | | ($0.29) | ($0.30) | ($0.24) | ($0.15) | ($0.07) | $0.00 |
| Diluted net | | | ($0.29) | ($0.30) | ($0.24) | ($0.15) | ($0.07) | $0.00 |
| |
| Weighted average common shares outstanding, basic (in shares) | | | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
| Weighted average common shares outstanding, diluted (in shares) | | | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
|